Evidence map›Paper›PMID 36421256›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Effect of Glycerol on Fosfomycin Activity against

Miriam Ortiz-Padilla, Inés Portillo-Calderón, Ana Velázquez-Escudero, Jesús Rodríguez-Baño, Álvaro Pascual, José Manuel Rodríguez-Martínez, Fernando Docobo-Pérez

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Investigation of antimicrobial synergism of actinomycin derivatives fromTurkish journal of biology = Turk biyoloji dergisi · 2026
    Article
  2. Fosfomycin resistance mechanisms inFrontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Miriam Ortiz-PadillaUnidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.ORCID 0000-0003-4660-6553
Inés Portillo-CalderónUnidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.
Ana Velázquez-EscuderoUnidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.
Jesús Rodríguez-BañoUnidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.ORCID 0000-0001-6732-9001
Álvaro PascualUnidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.
José Manuel Rodríguez-MartínezDepartamento de Microbiología, Facultad de Medicina, Universidad de Sevilla, 41009 Sevilla, Spain.
Fernando Docobo-PérezDepartamento de Microbiología, Facultad de Medicina, Universidad de Sevilla, 41009 Sevilla, Spain.ORCID 0000-0003-4038-6764
Hospital Universitario Virgen Macarena · ES

Funding

Instituto de Salud Carlos III CM20/0092Instituto de Salud Carlos III FI17/00235Instituto de Salud Carlos III PI19/01645Instituto de Salud Carlos III REIPI RD16/0016/0001
6 · The paper itself

Abstract

Fosfomycin is an antimicrobial that inhibits the biosynthesis of peptidoglycan by entering the bacteria through two channels (UhpT and GlpT). Glycerol is clinically used as a treatment for elevated intracranial pressure and induces the expression of

Indexed as

antimicrobial resistancefosfomycinoptimization treatment

Identifiers

PMID36421256
PMCPMC9686493
OpenAlexW4308970947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.